Patents by Inventor David Erkoboni

David Erkoboni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COLCHICINE FORMULATIONS; METHODS OF MAKING; AND METHODS OF USE THEREOF
    Publication number: 20150164831
    Abstract: Disclosed are new photostable colchicine formulations, methods of preparing the formulations, and uses thereof.
    Type: Application
    Filed: March 29, 2013
    Publication date: June 18, 2015
    Inventors: Richard H. Roberts, David Erkoboni, Bela Kraut, Maher Kudsi, Gandha V. Naringrekar
  • Controlled-release formulations, method of manufacture, and use thereof
    Patent number: 8632805
    Abstract: The present invention includes a controlled-release composition having a matrix. The matrix contains a pharmaceutically effective amount of an active agent or a pharmaceutically acceptable salt, solvate, ester, and/or prodrug thereof, an ionic non-gelling matrix polymer, and a pH modifier. The ionic non-gelling matrix polymer is practically insoluble and unswellable at a first aqueous fluid pH and is soluble at a second aqueous fluid pH. The pH modifier is present in an amount to control the release of the active agent from the composition. The controlled-release composition is substantially free of a gelling or swellable excipient. The present invention also provides methods of making and using the controlled-release compositions.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: January 21, 2014
    Assignee: Mutual Pharmaceutical Company, Inc.
    Inventors: Gandha V. Naringrekar, Kristin A. Arnold, David Erkoboni
  • Controlled-release formulations, method of manufacture, and use thereof
    Patent number: 7794750
    Abstract: The present invention includes a controlled-release composition having a matrix. The matrix contains a pharmaceutically effective amount of an active agent or a pharmaceutically acceptable salt or solvate thereof, an ionic non-gelling matrix polymer, and a pH modifier. The ionic non-gelling matrix polymer is practically insoluble and unswellable at a first aqueous fluid pH and is soluble at a second aqueous fluid pH. The pH modifier is present in an amount to control the release of the active agent from the composition. The controlled-release composition is substantially free of a gelling or swellable excipient and does not contain a functional coating or a lipophilic component. The present invention also provides methods of making and using the controlled-release compositions.
    Type: Grant
    Filed: December 8, 2008
    Date of Patent: September 14, 2010
    Assignee: Mutual Pharmaceutical Company, Inc.
    Inventors: Gandha V. Naringrekar, Kristin A. Arnold, David Erkoboni
  • CONTROLLED-RELEASE FORMULATIONS, METHOD OF MANUFACTURE, AND USE THEREOF
    Publication number: 20090317473
    Abstract: The present invention includes a controlled-release composition having a matrix. The matrix contains a pharmaceutically effective amount of an active agent or a pharmaceutically acceptable salt, solvate, ester, and/or prodrug thereof, an ionic non-gelling matrix polymer, and a pH modifier. The ionic non-gelling matrix polymer is practically insoluble and unswellable at a first aqueous fluid pH and is soluble at a second aqueous fluid pH. The pH modifier is present in an amount to control the release of the active agent from the composition. The controlled-release composition is substantially free of a gelling or swellable excipient. The present invention also provides methods of making and using the controlled-release compositions.
    Type: Application
    Filed: June 20, 2008
    Publication date: December 24, 2009
    Inventors: Gandha V. Naringrekar, Kristin A. Arnold, David Erkoboni
  • CONTROLLED-RELEASE FORMULATIONS, METHOD OF MANUFACTURE, AND USE THEREOF
    Publication number: 20090317471
    Abstract: The present invention includes a controlled-release composition having a matrix. The matrix contains a pharmaceutically effective amount of an active agent or a pharmaceutically acceptable salt or solvate thereof, an ionic non-gelling matrix polymer, and a pH modifier. The ionic non-gelling matrix polymer is practically insoluble and unswellable at a first aqueous fluid pH and is soluble at a second aqueous fluid pH. The pH modifier is present in an amount to control the release of the active agent from the composition. The controlled-release composition is substantially free of a gelling or swellable excipient and does not contain a functional coating or a lipophilic component. The present invention also provides methods of making and using the controlled-release compositions.
    Type: Application
    Filed: December 8, 2008
    Publication date: December 24, 2009
    Inventors: Gandha V. Naringrekar, Kristin A. Arnold, David Erkoboni